Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study

Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, Kleinschnitz C, Kleiter I, Lee D, Limmroth V, Maeurer M, Meuth S, Rieckmann P, Ruck T, Gold R, Linker RA

Research article (journal) | Peer reviewed

Details about the publication

JournalJournal of Neurology (J Neurol)
Volume265
Issue7
Page range1521-1527
StatusPublished
Release year2018
Language in which the publication is writtenEnglish
DOI10.1007/s00415-018-8871-2

Authors from the University of Münster

Meuth, Sven
Department for Neurology
Ruck, Tobias
Department for Neurology